Alzheimer's disease and HSV-1 infection;Choroba Alzheimera a infekcja wirusowa HSV-1

Neurologia i Neurochirurgia Polska

Volumn 40, Issue 1, 2006, Pages 57-61

  Geppert, Anita M ^a  

^a Poznan University of Medical Sciences Katedra i Klinika Neurologii Wieku Rozwojowego   (Poland)

Author keywords

Alzheimer's disease; HSV 1; Risk factors

Indexed keywords

AMYLOID; APOLIPOPROTEIN E2; APOLIPOPROTEIN E3; APOLIPOPROTEIN E4;

AGING; ALZHEIMER DISEASE; ARTICLE; BRAIN DEGENERATION; BRAIN NERVE CELL; CORRELATION ANALYSIS; GENETIC ANALYSIS; HERPES SIMPLEX; HERPES SIMPLEX VIRUS 1; HUMAN; HYPOTHESIS; MEDICAL RESEARCH; PRACTICE GUIDELINE; RISK FACTOR;

AGED; ALZHEIMER DISEASE; APOLIPOPROTEIN E4; APOLIPOPROTEINS E; HERPES SIMPLEX; HERPESVIRUS 1, HUMAN; HUMANS; RISK FACTORS;

EID: 32544453017     PISSN: 00283843     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Masters C.L., Simms G., Weinman N.A. i wsp. Amyloid plaque core protein in Alzheimer disease and Down syndrome. Proc Natl Acad Sci USA 1985; 82: 4245-4249.
2. Terry R.D., Masliah E., Salmon D.P. i wsp. Physical basis of cognitive alterations in Alzheimer's disease: synapse loss is the major correlate of cognitive impairment. Am Neurol 1991; 30: 572-580.
3. Liddell M.B., Lovestone S., Owen M.J. Genetic risk of Alzheimer's disease: advising relatives. Br J Psychiatry 2001; 178: 7-11.
4. Saunders A.M., Strittmatter W.J., Schmechel D. i wsp. Association of apolipoprotein E allele epsilon 4 with late-onset familial and sporadic Alzheimer's disease. Neurology 1993; 43: 1467-1472.
5. Farlow M.R., Lahiri D.K., Poirier J. i wsp. Treatment outcome of tacrine therapy depends on apolipoprotein genotype and gender of the subjects with Alzheimer's disease. Neuroradiology 1998; 50: 669-677.
6. McGeer P.L., Schulzer M., McGeer E.G. Arthritis and anti-inflammatory agents as possible protective factors for Alzheimer's disease: a review of 17 epidemiologic studies. Neurology 1996; 47: 425-432.
7. Bhojak T.J., DeKosky T.S., Ganguli M. i wsp. Genetic polymorphisms in the cathespin D and interleukin-6 genes and the risk of Alzheimer's disease. Neurosci Lett 2000; 288: 21-24.
8. Grimaldi L.M., Casadei V.M., Ferri C. Association of early-onset Alzheimer's disease with an interleukin-1α gene polymorphism. Ann Neurol 2000; 47: 361-365.
9. de la Torre J.C. Critically attained threshold of cerebral hypoperfusion: can it cause Alzheimer's disease? Am N Y Acad Sci 2000; 903: 424-436.
10. Goździcka-Józefiak A. Wirusologia molekularna. Wydawnietwo Naukowe UAM, 2004.
11. Dohner K., Wolfstein A., Prank U. i wsp. Function of dynein and dynactin in herpes simplex virus capsid transport. Mol Biol Cell 2002; 13: 2795-2809.
12. Satpute-Krishnan P., DeGiorgis J.A., Bearer E.L. Fast anterograde transport of herpes simplex virus: role for the amyloid precursor protein of Alzheimer's disease. Aging Cell 2003; 2: 305-318.
13. Jamieson G.A., Maitland N.J., Wilcock G.K. i wsp. Latent herpes simplex virus type 1 in normal and Alzheimer's disease brains. J Med Virol 1991; 33: 224-227.
14. Itzhaki R.F., Dobson C.B. Alzheimer's disease and herpes. CMAJ 2002; 167: 13.
15. Itzhaki R.F., Lin W.R., Shang D. i wsp. Herpes simplex virus type 1 in brain and risk of Alzheimer's disease. Lancet 1997; 349: 241-244.
16. Mori I., Kimura Y., Naiki H. i wsp. Reactivation of HSV-1 in the brain of patients with familial Alzheimer's disease. J Med Virol 2004; 73: 605-611.
17. Bloom D.C. HSV LAT and neuronal survival. Int Rev Immunol 2004; 23: 187-198.
18. Burgos J.S., Ramirez C., Sastre I. i wsp. Involvement of apolipoprotein E in the hematogenous route of herpes simplex virus type 1 to the central nervous system. J Virol 2002; 76: 12394-12398.
19. Lin W.R., Wozniak M.A., Esiri M.M. i wsp. Herpes simplex encephalitis: involvement of apolipoprotein E genotype. J Neurol Neurosurg Psychiatry 2001; 70: 117-119.
20. Corder F.H., Robertson K., Lannfelt L. i wsp. HIV-infected subjects with the E4 allele for APOE have excess dementia and peripheral neuropathy. Nat Med 1998; 4: 1182-1184.
21. Beffert U., Bertrand P., Champagne D. i wsp. HSV-1 in brain and risk of Alzheimer's disease. Lancet 1998; 351: 1330-1331.
22. Verreault R., Laurin D., Lindsay J. i wsp. Past exposure to vaccines and subsequent risk of Alzheimer's disease. CMAJ 2001; 165: 1495-1498.
23. Kamal A., Almenar-Queralt A., LeBlanc J.F. i wsp. Kinesin-mediated axonal transport of a membrane compartment containing beta-secretase and presenilin-1 requires APP. Nature 2001; 414: 643-648.
24. Goldstein L.S. Kinesin molecular motors: transport pathways, receptors, and human disease. Proc Natl Acad Sci USA 2001; 98: 6999-7003.
25. Bearer E.L. Perspectives on herpes-APP interactions. Aging Cell 2004; 3: 81-84.